Emerging evidence suggests that the extrapulmonary effects of pulmonary arterial hypertension may manifest in the form of vascular dysfunction in systemic circulation, metabolic/endocrine dysfunction, and skeletal and respiratory muscle dysfunction.
Individuals with preexisting respiratory diseases including asthma and COPD are among the groups identified as having a high risk for serious influenza-related complications.
The identification of biomarkers to distinguish endotypes that mediate neutrophilic asthma may guide the development of targeted interventions.
There has been ongoing controversy regarding the relative safety of e-cigarettes vs combustible cigarettes.
Challenges pertaining to the correct use of inhalers for asthma and COPD can limit the effectiveness of treatment.
The author suggests improvements for asthma treatment to reduce international mortality rates.
Immune checkpoint inhibitor therapies have improved survival in patients with non-small cell lung cancer, but they have also been linked to immune-related adverse events affecting various organs, including the lungs.
COPD is more common in older adults, who already have a higher burden of morbidity and mortality from influenza infection.
Among the estimated 235 million people worldwide who have asthma,1 a sizable portion are unable to achieve adequate disease control without high doses of inhaled corticosteroids (ICS) and/or oral corticosteroids, or are generally unresponsive to these therapies. These individuals, comprising approximately 5% to 10% of the total asthma population,2 are considered to have severe asthma.…
Post-ICU syndrome includes psychological effects — depression, anxiety, and PTSD — as well as worsened physical functioning.
